Dr.Zulcaif Ahmad
Macrolides
 History
 Chemistry
 Classification
 Mechanism of Action
 Antibacterial Spectrum
 Bacterial Resistance
 Pharmacokinetics
 Adverse Effects
Introduction
O
O O
O
CH3
HO
H3C
CH3
CH3
O
H3C
H3C
O
HO
CH3
N CH3
H3C
Picromycin
The term Macrolide was originally given to antibiotics
produced by species of Streptomyces.
In 1950 the first drug of this class was isolated: Picromycin
In 1952 Erythromycin and Carbomycin were introduced into
clinic.
General Structure
O
O
O
CH3
R1
H3C
CH3
CH3
O
H3C
OH
H3C
CH3
OH
O
O
HO
CH3
N
CH3
CH3
O OH
CH3
CH3
OR2
1 3
5
9
12
1`
1``
Erythromycin
Glycon
Aglycone
They all contain three characteristics parts in the molecule:
 A highly substituted macrocyclic lactone: aglycone.
 A ketone group.
 An amino desoxysugar: glycon, and in some of the macrolides, a
neutral desoxysugar which are glycosisically attached to the
aglycone ring.
The lactone ring usually has 12, 14, or 16 atoms and is
often unsaturated
macrolide antibiotics are weak bases and different
salts with pKa range of 6.0-9.0 can be formed on the
amino group.
Macrolides are water-insoluble molecules. Salts
prepared by glucoheptonic and lactobionic salts are
water soluble, whereas stearic acid and laurylsulfuric
acid salts are water-insoluble.
Macrolides are stable in aqueous solutions at or below
room temperature. They are unstable in acidic or basic
conditions or at high temperatures.
It has been the subject of chemical manipulations to:
a) Increase the water solubility of the drug for
parenteral dosage forms.
b) Increase the lipid solubility and hence chemical
stability of the drug against aqueous acidic
conditions as well as increase in oral absorption and
masking the bitter taste of the drug.
Chemical Instability of Macrolide Antibiotics
O
O
CH3
CH3
O
H3C
CH3
O
O
CH3
1 3
12 6
89
O
H3C
HO
H3C
Anhydroerythromycin
6,9;9,12-spiroketal
O OH
CH3
CH3
OR2
1``
O
HO
CH3
N
CH3
CH3
1`
 Macrolides are unstable under acidic conditions and
undergo an intramolecular reaction to form an
inactive cyclic ketal.
Chemical Instability..
The cyclic ketal is the cause of intestinal cramp
which is reported after the use of erythromycin.
Water-insoluble salts and enteric coated dosage
forms of macrolides have less such a side effect.
Water insoluble forms cannot take part in the
reactions which occur in aqueous solutions.
Stearate salt is an example of insoluble salts of
erytromycin.
Classification
Macrolides
 Erythromycin
 Clarithromycin
 Azithromycin
 Dirithromycin
 Telithromycin
 Oleandomycin
 Tylosin
 Spiramycin
Lincosamides
Lincomycin
Clindamycin
Mechanism of Action
 Macrolides attach to the 50s portion of bacterial
ribosomes and inhibit the protein synthesis.
 Prevent translocation during elongation of protein
synthesis
 Their binding site is either identical or in close
proximity to that for clindamycin and chloramphenicol.
Mechanism of action of erythromycin and clindamycin.
Spectrum of Antibacterial Activity
Macrolides are similar to penicillins regarding their
spectrum of activity.
They are effective against penicillin-resistant strains.
Macrolides are effective against most of the G(+)
bacteria, cocci or bacillus, they have antibiotic
activity against G(-) cocci ,especially Neisseria Spp
too.
Macrolide antibiotics are effective against
Mycoplasma, Chlamydia, Campylobacter and
Legionella in contrast to penicillins.
They are less effective against G(-) bacteria, though
some strains of H. influenza and Brucella are
sensitive to the antibacterial activity of this class of
antibiotics.
Typical therapeutic applications of macrolides.
Bacterial Resistance
 Methylation of a guanine residue on ribosomal RNA leads
to lower affinity toward macrolides
 An active efflux system
 presence of a plasmid-associated erythromycin esterase.
 Clarithromycin and azithromycin show cross-resistance
with erythromycin, but telithromycin can be effective
against macrolide-resistant organisms.
 Lack of cell wall permeability to macrolides is the reason
why G(-) bacteria are resistant to antibacterial effects of
these agents.
Pharmacokinetics
 Absorption: Enteric coated preparations protect the
antibiotic from gastric acid destruction allowing oral
absorption
Also when stable esterified salts are used.
 Fate: Widely distributed to all tissues except CNS.
 Excretion: Metabolized by liver and excreted by bile .
 Tylosin and telmicosin excreted unchanged in bile and
urine.
Administration and fate of the macrolide antibiotics.
Some properties of the macrolide antibiotics.
Inhibition of the cytochrome P450 system by erythromycin,
clarithromycin, and telithromycin.
Adverse Effects
 Epigastric distress: Common with erythromycin
 Cholestatic jaundice: Especially with the estolate form of
erythromycin
 Ototoxicity: Transient deafness associated with
erythromycin, at high dosages.
 Contraindications: Patients with hepatic dysfunction.
 Interactions: Inhibit the hepatic metabolism of a number
of drugs
Some adverse effects of macrolide antibiotics.
Clinical Application
of Erythromycin
It is used to treat
The upper part of the respiratory tract infections,
Soft tissue G(+) infections,
Mycoplasma pneumonia caused pneumonia,
Campylobacter jejuni enteritis,
Chlamydia infections.
Gonorrhoea.
It is a good choice for penicillin-sensitive cases.
Clarithromycin
O
O
O
CH3
HO
H3C
CH3
CH3
O
H3C
OH
H3C
O
O
O
HO
CH3
N
CH3
CH3
O OH
CH3
CH3
OH
1 3
5
9
12
1`
1``
Clarithromycin
H3C
CH3
6
 6-Methyl ether of erythromycin.
 Cannot undergo cyclic ketal formation, so doesn’t cause cramp in
GI.
 Higher blood concentrations.
 More lipophyl.
 Lower doses with less intervals.
Azithromycin
O
O
CH3
HO
H3C
CH3
O
H3C
OH
CH3
OH
O
O
HO
CH3
N
CH3
CH3
O OH
CH3
CH3
OCH3
1 3
5
12
1`
1``
N
CH3
H3C
H3C
Azithromycin
 Azalide, a semisynthetic macrolide with a15 membered ring.
 Stable under acidic conditions, because it doesn’t form cyclic
ketal.
 In the treatment of urogenital infections caused by N.
gonorrhoeae and Chlamidia trachomatis.
 Longer half-life.
Oleandomycin
O
O
O
CH3
H3C
CH3
O
H3C
OH
H3C
H3C
O
O
RO
CH3
N
CH3
CH3
O OR
CH3
1 3
5
9
12
1`
1``
Oleandomycin, R=H
Troleandomycin R=COCH3
6
O
O
CH3
 Oleandomycin is isolated from Streptomyces antibuticus.
 Bacteriostatic effects the same as erythromycin.
Lincosamide
 First lincosamide to be discovered is lincomycin, isolated from
Streptomyces lincolnensis
 Lincosamides are derivatives of an amino acid and a sulfur-
containing octose.
 Lincosamides, macrolides, and chloramphenicol, although not
structurally related, seem to act at this same site.
 The lincosamides are bacteriostatic or bactericidal depending on
the concentration.
 Activity is enhanced at an alkaline pH.
 Lincomycin has been superseded by clindamycin, which exhibits
improved antibacterial activity.
Clindamycin
 Mechanism same as that of erythromycin
 Good for anaerobic organisms (Bacteroids)
 Resistance like erythromycin
 Well absorbed by the oral route.
 It distributes well into all body fluids except the CSF.
 Penetration into bone occurs even in the absence of
inflammation.
 The drug is excreted into the bile or urine .
Adverse effect:
 In addition to skin rashes, serious adverse effect is fatal
pseudomembranous colitis caused by C. difficile, which is
treated by metronidazole or vancomycin .
Administration and fate of clindamycin.
Ketolides
 Ketolides are antibiotics belonging to the macrolides
group.
 Ketolides are derived from erythromycin by
substituting the cladinose sugar with a keto-group and
attaching a cyclic carbamate group in the lactone ring.
 These modifications give ketolides much broader
spectrum than other macrolides.
 Ketolides are effective against macrolide-resistant
bacteria as well as having a structural modification
that makes them poor substrates for efflux-pump
mediated resistance.
 Ketolides block protein synthesis by binding to
ribosomal subunits and may also inhibit the formation
of newly forming ribosomes.
 The only ketolide on the market at this moment is
Telithromycin, which is sold under the brand name
of Ketek.
 Other ketolides in development include Cethromycin
and Solithromycin.

Macrolides and lincosamide

  • 1.
  • 2.
    Macrolides  History  Chemistry Classification  Mechanism of Action  Antibacterial Spectrum  Bacterial Resistance  Pharmacokinetics  Adverse Effects
  • 3.
    Introduction O O O O CH3 HO H3C CH3 CH3 O H3C H3C O HO CH3 N CH3 H3C Picromycin Theterm Macrolide was originally given to antibiotics produced by species of Streptomyces. In 1950 the first drug of this class was isolated: Picromycin In 1952 Erythromycin and Carbomycin were introduced into clinic.
  • 4.
    General Structure O O O CH3 R1 H3C CH3 CH3 O H3C OH H3C CH3 OH O O HO CH3 N CH3 CH3 O OH CH3 CH3 OR2 13 5 9 12 1` 1`` Erythromycin Glycon Aglycone They all contain three characteristics parts in the molecule:  A highly substituted macrocyclic lactone: aglycone.  A ketone group.  An amino desoxysugar: glycon, and in some of the macrolides, a neutral desoxysugar which are glycosisically attached to the aglycone ring.
  • 5.
    The lactone ringusually has 12, 14, or 16 atoms and is often unsaturated macrolide antibiotics are weak bases and different salts with pKa range of 6.0-9.0 can be formed on the amino group. Macrolides are water-insoluble molecules. Salts prepared by glucoheptonic and lactobionic salts are water soluble, whereas stearic acid and laurylsulfuric acid salts are water-insoluble. Macrolides are stable in aqueous solutions at or below room temperature. They are unstable in acidic or basic conditions or at high temperatures.
  • 6.
    It has beenthe subject of chemical manipulations to: a) Increase the water solubility of the drug for parenteral dosage forms. b) Increase the lipid solubility and hence chemical stability of the drug against aqueous acidic conditions as well as increase in oral absorption and masking the bitter taste of the drug.
  • 7.
    Chemical Instability ofMacrolide Antibiotics O O CH3 CH3 O H3C CH3 O O CH3 1 3 12 6 89 O H3C HO H3C Anhydroerythromycin 6,9;9,12-spiroketal O OH CH3 CH3 OR2 1`` O HO CH3 N CH3 CH3 1`  Macrolides are unstable under acidic conditions and undergo an intramolecular reaction to form an inactive cyclic ketal.
  • 8.
    Chemical Instability.. The cyclicketal is the cause of intestinal cramp which is reported after the use of erythromycin. Water-insoluble salts and enteric coated dosage forms of macrolides have less such a side effect. Water insoluble forms cannot take part in the reactions which occur in aqueous solutions. Stearate salt is an example of insoluble salts of erytromycin.
  • 9.
    Classification Macrolides  Erythromycin  Clarithromycin Azithromycin  Dirithromycin  Telithromycin  Oleandomycin  Tylosin  Spiramycin
  • 10.
  • 11.
    Mechanism of Action Macrolides attach to the 50s portion of bacterial ribosomes and inhibit the protein synthesis.  Prevent translocation during elongation of protein synthesis  Their binding site is either identical or in close proximity to that for clindamycin and chloramphenicol.
  • 12.
    Mechanism of actionof erythromycin and clindamycin.
  • 13.
    Spectrum of AntibacterialActivity Macrolides are similar to penicillins regarding their spectrum of activity. They are effective against penicillin-resistant strains. Macrolides are effective against most of the G(+) bacteria, cocci or bacillus, they have antibiotic activity against G(-) cocci ,especially Neisseria Spp too. Macrolide antibiotics are effective against Mycoplasma, Chlamydia, Campylobacter and Legionella in contrast to penicillins. They are less effective against G(-) bacteria, though some strains of H. influenza and Brucella are sensitive to the antibacterial activity of this class of antibiotics.
  • 14.
  • 15.
    Bacterial Resistance  Methylationof a guanine residue on ribosomal RNA leads to lower affinity toward macrolides  An active efflux system  presence of a plasmid-associated erythromycin esterase.  Clarithromycin and azithromycin show cross-resistance with erythromycin, but telithromycin can be effective against macrolide-resistant organisms.  Lack of cell wall permeability to macrolides is the reason why G(-) bacteria are resistant to antibacterial effects of these agents.
  • 16.
    Pharmacokinetics  Absorption: Entericcoated preparations protect the antibiotic from gastric acid destruction allowing oral absorption Also when stable esterified salts are used.  Fate: Widely distributed to all tissues except CNS.  Excretion: Metabolized by liver and excreted by bile .  Tylosin and telmicosin excreted unchanged in bile and urine.
  • 17.
    Administration and fateof the macrolide antibiotics.
  • 18.
    Some properties ofthe macrolide antibiotics.
  • 19.
    Inhibition of thecytochrome P450 system by erythromycin, clarithromycin, and telithromycin.
  • 20.
    Adverse Effects  Epigastricdistress: Common with erythromycin  Cholestatic jaundice: Especially with the estolate form of erythromycin  Ototoxicity: Transient deafness associated with erythromycin, at high dosages.  Contraindications: Patients with hepatic dysfunction.  Interactions: Inhibit the hepatic metabolism of a number of drugs
  • 21.
    Some adverse effectsof macrolide antibiotics.
  • 22.
    Clinical Application of Erythromycin Itis used to treat The upper part of the respiratory tract infections, Soft tissue G(+) infections, Mycoplasma pneumonia caused pneumonia, Campylobacter jejuni enteritis, Chlamydia infections. Gonorrhoea. It is a good choice for penicillin-sensitive cases.
  • 23.
    Clarithromycin O O O CH3 HO H3C CH3 CH3 O H3C OH H3C O O O HO CH3 N CH3 CH3 O OH CH3 CH3 OH 1 3 5 9 12 1` 1`` Clarithromycin H3C CH3 6 6-Methyl ether of erythromycin.  Cannot undergo cyclic ketal formation, so doesn’t cause cramp in GI.  Higher blood concentrations.  More lipophyl.  Lower doses with less intervals.
  • 24.
    Azithromycin O O CH3 HO H3C CH3 O H3C OH CH3 OH O O HO CH3 N CH3 CH3 O OH CH3 CH3 OCH3 1 3 5 12 1` 1`` N CH3 H3C H3C Azithromycin Azalide, a semisynthetic macrolide with a15 membered ring.  Stable under acidic conditions, because it doesn’t form cyclic ketal.  In the treatment of urogenital infections caused by N. gonorrhoeae and Chlamidia trachomatis.  Longer half-life.
  • 25.
    Oleandomycin O O O CH3 H3C CH3 O H3C OH H3C H3C O O RO CH3 N CH3 CH3 O OR CH3 1 3 5 9 12 1` 1`` Oleandomycin,R=H Troleandomycin R=COCH3 6 O O CH3  Oleandomycin is isolated from Streptomyces antibuticus.  Bacteriostatic effects the same as erythromycin.
  • 26.
    Lincosamide  First lincosamideto be discovered is lincomycin, isolated from Streptomyces lincolnensis  Lincosamides are derivatives of an amino acid and a sulfur- containing octose.  Lincosamides, macrolides, and chloramphenicol, although not structurally related, seem to act at this same site.  The lincosamides are bacteriostatic or bactericidal depending on the concentration.  Activity is enhanced at an alkaline pH.  Lincomycin has been superseded by clindamycin, which exhibits improved antibacterial activity.
  • 27.
    Clindamycin  Mechanism sameas that of erythromycin  Good for anaerobic organisms (Bacteroids)  Resistance like erythromycin  Well absorbed by the oral route.  It distributes well into all body fluids except the CSF.  Penetration into bone occurs even in the absence of inflammation.  The drug is excreted into the bile or urine . Adverse effect:  In addition to skin rashes, serious adverse effect is fatal pseudomembranous colitis caused by C. difficile, which is treated by metronidazole or vancomycin .
  • 28.
    Administration and fateof clindamycin.
  • 29.
    Ketolides  Ketolides areantibiotics belonging to the macrolides group.  Ketolides are derived from erythromycin by substituting the cladinose sugar with a keto-group and attaching a cyclic carbamate group in the lactone ring.  These modifications give ketolides much broader spectrum than other macrolides.
  • 32.
     Ketolides areeffective against macrolide-resistant bacteria as well as having a structural modification that makes them poor substrates for efflux-pump mediated resistance.  Ketolides block protein synthesis by binding to ribosomal subunits and may also inhibit the formation of newly forming ribosomes.  The only ketolide on the market at this moment is Telithromycin, which is sold under the brand name of Ketek.  Other ketolides in development include Cethromycin and Solithromycin.

Editor's Notes

  • #33 Macrolides and ketolides inhibit protein synthesis by the same mode of action. They bind within the exit tunnel of the large ribosomal subunit, thus blocking the exit of nascent polypeptides. The large ribosomal subunit consists of 2 pieces of rRNA (23S and 5S) and 31 ribosomal proteins. Macrolides and ketolides bind to specific residues of 23S rRNA—namely, the adenine at positions 2058 (A2058) and 2059 (A2059). These specific adenine residues are on domain V of 23S rRNA. In addition, telithromycin binds, via the 11,12 carbamate bridge containing the alkyl-aryl extension, to a specific adenine (A752) on domain II of the 23S rRNA, a region near domain V in the 3-dimensional structure of the ribosome (figure 2). In susceptible organisms, telithromycin binds 10-fold more tightly to ribosomes than erythromycin does, because of the binding to domain II